loadpatents
name:-0.023902177810669
name:-0.014945983886719
name:-0.01655912399292
Lafaye; Pierre Patent Filings

Lafaye; Pierre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lafaye; Pierre.The latest application filed is for "severe acute respiratory syndrome (sars) - associated coronavirus diagnostics".

Company Profile
7.15.18
  • Lafaye; Pierre - Malakoff FR
  • LAFAYE; Pierre - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nanobodies suitable for neuron regeneration therapy
Grant 11,339,211 - Prehaud , et al. May 24, 2
2022-05-24
Severe Acute Respiratory Syndrome (sars) - Associated Coronavirus Diagnostics
App 20220042987 - VAN DER WERF; Sylvie ;   et al.
2022-02-10
Severe Acute Respiratory Syndrome (sars) - Associated Coronavirus Diagnostics
App 20210311054 - VAN DER WERF; Sylvie ;   et al.
2021-10-07
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
Grant 11,124,563 - Lafaye , et al. September 21, 2
2021-09-21
Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics
Grant 10,948,490 - Van Der Werf , et al. March 16, 2
2021-03-16
Nanobodies Suitable For Neuron Regeneration Therapy
App 20210040187 - PREHAUD; Christophe ;   et al.
2021-02-11
Oligopeptide and methods for producing conjugates thereof
Grant 10,787,505 - Lafaye , et al. September 29, 2
2020-09-29
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof
App 20200165329 - LAFAYE; Pierre ;   et al.
2020-05-28
Nanobodies suitable for neuron regeneration therapy
Grant 10,640,552 - Prehaud , et al.
2020-05-05
In vitro blood-brain barrier model
Grant 10,591,466 - Prehaud , et al.
2020-03-17
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
Grant 10,538,582 - Lafaye , et al. Ja
2020-01-21
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof
App 20190077853 - Lafaye; Pierre ;   et al.
2019-03-14
Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
Grant 10,174,105 - Rougeon , et al. J
2019-01-08
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
Grant 10,155,054 - Lafaye , et al. Dec
2018-12-18
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
Grant 10,087,245 - Lafaye , et al. October 2, 2
2018-10-02
Paper Device For Genetic Diagnosis
App 20180245144 - MAGRO; Laura ;   et al.
2018-08-30
Nanobodies Suitable For Neuron Regeneration Therapy
App 20170283490 - PREHAUD; Christophe ;   et al.
2017-10-05
New In Vitro Blood-brain Barrier Model
App 20170241988 - PREHAUD; Christophe ;   et al.
2017-08-24
Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
Grant 9,738,712 - Lafaye , et al. August 22, 2
2017-08-22
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20170165383 - LAFAYE; Pierre ;   et al.
2017-06-15
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof
App 20170058022 - LAFAYE; Pierre ;   et al.
2017-03-02
Use Of Vhh Antibodies For The Preparation Of Peptide Vectors For Delivering A Substance Of Interest And Their Applications
App 20170002065 - ROUGEON; Francois ;   et al.
2017-01-05
Oligopeptide And Methods For Producing Conjugates Thereof
App 20160355575 - LAFAYE; Pierre ;   et al.
2016-12-08
Camelid Single-domain Antibody Directed Against Amyloid Beta And Methods For Producing Conjugates Thereof
App 20160347831 - LAFAYE; Pierre ;   et al.
2016-12-01
VHH antibodies used as peptide vectors for delivering a substance of interest
Grant 9,387,260 - Rougeon , et al. July 12, 2
2016-07-12
Use Of Anti-fcyri And/or Anti-fcyriia Antibodies For Treating Arthritis, Inflammation, Thrombocytopenia And Allergic Shock
App 20150322152 - BRUHNS; Pierre ;   et al.
2015-11-12
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20140206081 - Lafaye; Pierre ;   et al.
2014-07-24
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
Grant 8,460,888 - Lafaye , et al. June 11, 2
2013-06-11
Variable Domains Of Camelid Heavy-chain Antibodies Directed Against Glial Fibrillary Acidic Proteins
App 20110250211 - Lafaye; Pierre ;   et al.
2011-10-13
Use Of A Camelid Single-domain Antibody For Detecting An Oligomeric Form Of An Amyloid Beta Peptide And Its Applications
App 20100266576 - Rougeon; Francois ;   et al.
2010-10-21
Use Of Vhh Antibodies For The Preparation Of Peptide Vectors For Delivering A Substance Of Interest And Their Applications
App 20100021384 - ROUGEON; Francois ;   et al.
2010-01-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed